Note*: This report requires 5-10 business days to complete.
DelveInsight’s “Multiple Myeloma - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Multiple Myeloma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Multiple Myeloma from 2010-2020.Multiple myeloma are a type of blood cancer that affects the plasma cells. In multiple myeloma, malignant plasma cells accumulate in the bone marrow, crowding out the normal plasma cells that help fight infections. These malignant plasma cells then produce abnormal proteins (m protein) which may cause tumors, damage the kidneys, and impair immune system function. In some cases, the malignant cells may cause a single tumor, called a solitary plasmacytoma, but if multiple tumors are formed, then the disease is called multiple myeloma. Multiple myeloma develops in 6.1 per 100,000 people per year. With conventional treatment, median survival is 3–4 years, which may be extended to 5–7 years or longer with advanced treatments. The five year survival rate is 45%.In the United States in 2014, there will be an estimated 24,050 new cases and 11,090 deaths. Results of a recent study found the incidence of myeloma to be 9.5 cases per 100,000 African Americans and 4.1 cases per 100,000 Caucasian Americans. Among African Americans, myeloma is one of the top 10 leading causes of cancer death. With many possible approaches to study and work through, future strategies will revolve around exploration of the effectiveness of combinations that incorporate new agents in various disease and treatment settings. The use of genetic profiles to further delineate groups for different treatment approaches should enable the introduction of patient-specific treatment programmes in the future.
Scope
• Report covers the disease overview including etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Multiple Myeloma for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Multiple Myeloma
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Multiple Myeloma Market
• Global Epidemiology of Multiple Myeloma Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Multiple Myeloma Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Multiple Myeloma (2011-2020)
• Table 7: Multiple Myeloma Global Market Size (USD Millions), (2011-2014)
• Table 8: Multiple Myeloma Global Market Size (USD Millions), (2015-2020)
• Table 9: Multiple Myeloma US Market Size (USD Millions), (2011-2014)
• Table 10: Multiple Myeloma US Market Size (USD Millions), (2015-2020)
• Table 11: Multiple Myeloma United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Multiple Myeloma Germany Market Size (USD Millions), (2015-2020)
• Table 13: Multiple Myeloma United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Multiple Myeloma United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Multiple Myeloma France Market Size (USD Millions), (2011-2014)
• Table 16: Multiple Myeloma France Market Size (USD Millions), (2015-2020)
• Table 17: Multiple Myeloma Italy Market Size (USD Millions), (2011-2014)
• Table 18: Multiple Myeloma Italy Market Size (USD Millions), (2015-2020)
• Table 19: Multiple Myeloma Spain Market Size (USD Millions), (2011-2014)
• Table 20: Multiple Myeloma Spain Market Size (USD Millions), (2015-2020)
• Table 21: Multiple Myeloma Japan Market Size (USD Millions), (2011-2014)
• Table 22: Multiple Myeloma Japan Market Size (USD Millions), (2015-2020)
• Table 23: Multiple Myeloma ROW Market Size (USD Millions), (2011-2014)
• Table 24: Multiple Myeloma ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Multiple Myeloma Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Multiple Myeloma (2011-2020)
• Figure 3: Multiple Myeloma Global Market Size (USD Millions), (2011-2014)
• Figure 4: Multiple Myeloma Global Market Size (USD Millions), (2015-2020)
• Figure 5: Multiple Myeloma US Market Size (USD Millions), (2011-2014)
• Figure 6: Multiple Myeloma US Market Size (USD Millions), (2015-2020)
• Figure 7: Multiple Myeloma Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Multiple Myeloma Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Multiple Myeloma United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Multiple Myeloma United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Multiple Myeloma France Market Size (USD Millions), (2011-2014)
• Figure 12: Multiple Myeloma France Market Size (USD Millions), (2015-2020)
• Figure 13: Multiple Myeloma Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Multiple Myeloma Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Multiple Myeloma Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Multiple Myeloma Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Multiple Myeloma Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Multiple Myeloma Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Multiple Myeloma ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Multiple Myeloma ROW Market Size (USD Millions), (2015-2020)
